Smith A M, Klugman K P
MRC/SAIMR/WITS Pneumococcal Diseases Research Unit, Department of Clinical Microbiology and Infectious Diseases, South African Institute for Medical Research, Johannesburg, South Africa.
Antimicrob Agents Chemother. 1998 Jun;42(6):1329-33. doi: 10.1128/AAC.42.6.1329.
High-level penicillin resistance in pneumococci is due to alterations in penicillin-binding proteins (PBPs) 2X, 2B, and 1A. We have sequenced the penicillin-binding domain of PBP 1A from penicillin-resistant South African pneumococcal isolates and have identified amino acid substitutions which are common to all the resistant isolates analyzed. Site-directed mutagenesis was then used to determine whether particular amino acid substitutions at specific positions in PBP 1A mediate penicillin resistance. PCR was used to isolate PBP 2X, 2B, and 1A genes from clinical isolate 8303 (penicillin MIC, 4 micrograms/ml). These wild-type PBP genes were cloned into pGEM-3Zf and were used as the transforming DNA. Susceptible strain R6 (MIC, 0.015 microgram/ml) was first transformed with PBP 2X and 2B DNA, resulting in PBP 2X/2B-R6 transformants for which MICs were 0.25 microgram/ml. When further transformed with PBP 1A DNA, 2X/2B/1A-R6 transformants for which MICs were 1.5 micrograms/ml were obtained. Site-directed mutagenesis of the PBP 1A gene from isolate 8303 was then used to reverse particular amino acid substitutions, followed by transformation of PBP 2X/2B-R6 transformants with the mutagenized PBP 1A DNA. For PBP 2X/2B/1A-R6 transformants, the introduction of the reversal of Thr-371 by Ser or Ala in PBP 1A decreased the MIC from 1.5 to 0.5 micrograms/ml, whereas the reversal of four consecutive amino acid substitutions (Thr-574 by Asn, Ser-575 by Thr, Gln-576 by Gly, and Phe-577 by Tyr) decreased the MIC from 1.5 to 0.375 micrograms/ml. These data reveal that amino acid residue 371 and residues 574 to 577 of PBP 1A are important positions in PBP 1A with respect to the interaction with penicillin and the development of resistance.
肺炎球菌对青霉素的高水平耐药性是由于青霉素结合蛋白(PBPs)2X、2B和1A发生了改变。我们对来自南非耐青霉素肺炎球菌分离株的PBP 1A的青霉素结合结构域进行了测序,并鉴定出所有分析的耐药分离株共有的氨基酸替换。然后利用定点诱变来确定PBP 1A中特定位置的特定氨基酸替换是否介导青霉素耐药性。采用聚合酶链反应(PCR)从临床分离株8303(青霉素最低抑菌浓度[MIC],4微克/毫升)中分离PBP 2X、2B和1A基因。这些野生型PBP基因被克隆到pGEM-3Zf中,并用作转化DNA。首先用PBP 2X和2B DNA转化敏感菌株R6(MIC,0.015微克/毫升),得到MIC为0.25微克/毫升的PBP 2X/2B-R6转化体。当用PBP 1A DNA进一步转化时,得到MIC为1.5微克/毫升的2X/2B/1A-R6转化体。然后利用定点诱变对分离株8303的PBP 1A基因进行特定氨基酸替换的反向操作,随后用诱变后的PBP 1A DNA转化PBP 2X/2B-R6转化体。对于PBP 2X/2B/1A-R6转化体,在PBP 1A中用丝氨酸或丙氨酸将苏氨酸-371反向替换可使MIC从1.5降至0.5微克/毫升,而四个连续氨基酸替换(苏氨酸-574被天冬酰胺替换、丝氨酸-575被苏氨酸替换、谷氨酰胺-576被甘氨酸替换、苯丙氨酸-577被酪氨酸替换)的反向操作可使MIC从1.5降至0.375微克/毫升。这些数据表明,就与青霉素的相互作用和耐药性的产生而言,PBP 1A的氨基酸残基371以及残基574至577是PBP 1A中的重要位置。